Is MDG1.DE stock a buy after the pre-market drop?

The MDG1.DE stock drop creates a speculative bounce opportunity, not a clear buy. If catalysts appear, short-term trades could work. Keep positions small, stops below €0.08, and validate with news or volume before adding exposure.

What price targets should traders watch for MDG1.DE stock?

Watch **€0.30** as the first resistance test, **€0.80** as a medium target, and **€1.50** as a recovery level. These targets assume improved newsflow and higher volume; they are model projections, not guarantees.

How does Meyka AI rate MDG1.DE stock and why?

Meyka AI rates MDG1.DE **57.72/100 (C+, HOLD)**. The score blends benchmark and sector comparison, financial growth, key metrics and analyst signals. The rating recognises rebound potential but flags weak earnings and liquidity risks.

What are the main risks for MDG1.DE stock traders?

Main risks include low liquidity, potential dilution, negative operating cash flow, and pipeline delays. MDG1.DE stock can gap widely; use strict stops and trade small positions to manage risk.

DE Stocks

MDG1.DE Medigene AG -27.64% to €0.13 pre-market 21 Jan 2026: oversold bounce watch

ByDanny Kontos January 21, 2026January 21, 2026

The MDG1.DE stock fell sharply pre-market on 21 Jan 2026, trading at €0.13 after a 27.64% drop. This rapid sell-off pushes the share deep below its 50-day average of €1.41 and creates a classic oversold-bounce setup for short-term traders on XETRA in Germany. We highlight volume, valuation and catalysts that could trigger a mean reversion and outline measurable price targets and risks for investors.